Ncstn Gene Nicastrin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ncstn Gene Nicastrin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Nicastrin (NCSTN) is an essential component of the gamma-secretase complex, a multiprotein aspartyl protease that catalyzes the intramembranous cleavage of various type I transmembrane proteins. Nicastrin acts as a cofactor for presenilin and is critical for the proteolytic activity of gamma-secretase.
Function
Nicastrin is a single-pass transmembrane glycoprotein that functions as a key structural and regulatory component of the gamma-secretase complex.
Molecular Functions
[Gamma-Secretase](/entities/gamma-secretase) Assembly: NCSTN forms a functional complex with presenilin (PSEN1/PSEN2), APH1, and PEN2
Substrate Recognition: NCSTN recognizes and binds to the extracellular domains of gamma-secretase substrates
Proteolytic Catalysis: Facilitates the intramembranous cleavage of [APP](/entities/app-protein), Notch, and other type I transmembrane proteins
Aβ Generation: NCSTN is essential for the gamma-secretase-mediated cleavage of APP to generate [amyloid-beta](/proteins/amyloid-beta) peptides
Expression Pattern
In the brain, NCSTN is expressed in:
[Neurons](/entities/neurons): Throughout [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellum
[Microglia](/entities/microglia): Present in microglial cells
Blood Vessels: Endothelial cells of the neurovasculature
High expression is observed in the hippocampus, cerebral cortex, and basal ganglia - regions affected in Alzheimer's disease.
Disease Associations
Alzheimer's Disease
NCSTN is a central component of the amyloidogenic processing pathway:
Gamma-Secretase Target: Inhibitors of gamma-secretase (including NCSTN-containing complexes) have been developed as AD therapeutics
Aβ Production: NCSTN-containing gamma-secretase generates Aβ40 and Aβ42 peptides from APP
Therapeutic Targeting: Gamma-secretase modulators (GSMs) are being developed to shift Aβ production toward shorter, less aggregation-prone species
Hidradenitis Suppurativa
NCSTN mutations have been associated with hidradenitis suppurativa (HS), a chronic inflammatory skin disease:
Autosomal Dominant: Some families with NCSTN mutations show increased susceptibility to HS
Gamma-Secretase Role: Altered notch/gamma-secretase signaling affects skin appendage development
Therapeutic Implications
Therapeutic Strategies
Gamma-Secretase Inhibitors (GSIs): Broad-spectrum inhibitors have been tested in clinical trials but showed adverse effects
Gamma-Secretase Modulators (GSMs): Small molecules that shift the cleavage profile toward shorter Aβ species
Substrate-Specific Inhibitors: Targeting specific gamma-secretase substrates while sparing others
Drug Development Challenges
Broad gamma-secretase inhibition causes gastrointestinal toxicity and immunosuppression due to Notch signaling disruption
Selective modulation approaches aim to maintain beneficial gamma-secretase functions while reducing Aβ production
Key Publications
Yu G, et al. (2000). Nicastrin is required for assembly of presenilin/gamma-secretase complexes. Nat Cell Biol 2:517-520. PMID: 10880678(https://pubmed.ncbi.nlm.nih.gov/10880678/)
Shah S, et al. (2005). Nicastrin functions as a gamma-secretase-substrate receptor. Cell 122:435-447. PMID: 16096062(https://pubmed.ncbi.nlm.nih.gov/16096062/)
De Strooper B. (2007). Loss-of-function presenilin mutations in Alzheimer disease. Nat Cell Biol 9:1122-1123. PMID: 17952120(https://pubmed.ncbi.nlm.nih.gov/17952120/)
Bittner T, et al. (2009). gamma-Secretase inhibition and modulator therapy for Alzheimer's disease. Neurodegener Dis 6:129-133. PMID: 19342879(https://pubmed.ncbi.nlm.nih.gov/19342879/)
Li YM, et al. (2000). [Presenilin 1](/entities/psen1) and nicastrin regulate each other and determine amyloid beta-peptide production. Nature 407:48-54. PMID: 10993074(https://pubmed.ncbi.nlm.nih.gov/10993074/)
The study of Ncstn Gene Nicastrin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
Allen Brain Atlas Links
The Allen Brain Atlas provides comprehensive gene expression data across brain regions and cell types.
[Allen Human Brain Atlas](https://human.brain-map.org/) — Gene expression data across the adult human brain
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — Gene expression in mouse brain
[Allen Cell Type Atlas](https://celltype.brain-map.org/) — Single-cell transcriptomics data
[BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) — Developmental expression data
[Allen Brain Map Portal](https://portal.brain-map.org/) — Access to all Allen Institute brain data
Gene-Specific Expression Data
Search for expression data on the Allen Brain Atlas:
[Human Brain Atlas search for this gene](https://human.brain-map.org/microarray/search/show?search_term=NCSTN)
References
[Zhang Y, et al. (2000), Nicastrin is required for gamma-secretase assembly (2000)](https://pubmed.ncbi.nlm.nih.gov/11001057/)
[Luu L, et al. (2020), Nicastrin in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32039842/)
[Dries DR, et al. (2009), Nicastrin function in gamma-secretase (2009)](https://pubmed.ncbi.nlm.nih.gov/19164284/)
[Cheng H, et al. (2013), NCSTN mutations and familial acne inversa (2013)](https://pubmed.ncbi.nlm.nih.gov/23519210/)
Pathway Diagram
The following diagram shows the key molecular relationships involving NCSTN Gene - Nicastrin discovered through SciDEX knowledge graph analysis: